Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children

This publication has 28 references indexed in Scilit:

• Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants
  The Pediatric Infectious Disease Journal, 2011
• Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
  BMC Public Health, 2011
• Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children
  Human Vaccines, 2011
• Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose
  Vaccine, 2011
• Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
  PLOS Medicine, 2010
• Global, regional, and national causes of child mortality in 2008: a systematic analysis
  The Lancet, 2010
• Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months
  The Pediatric Infectious Disease Journal, 2010
• Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
  BMC Pediatrics, 2010
• Evaluation of Pneumococcal Polysaccharide Immunoassays Using a 22F Adsorption Step with Serum Samples from Infants Vaccinated with Conjugate Vaccines
  Clinical and Vaccine Immunology, 2010
• Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
  The Lancet, 2006